| Title |
Aripiprazole in the treatment of challenging behaviour in adults with autism spectrum disorder
|
|---|---|
| Published in |
Psychopharmacology, April 2012
|
| DOI | 10.1007/s00213-012-2723-z |
| Pubmed ID | |
| Authors |
Iain Jordan, Dene Robertson, Marco Catani, Michael Craig, Declan Murphy |
| Abstract |
Autism spectrum disorders (ASD) are associated with repetitive behaviours and often also with hyperactivity, aggression, self-injurious behaviour, irritability and lability of mood. There is emerging evidence that aripiprazole, an antipsychotic with partial agonist dopaminergic effect, may be effective in the treatment of these challenging behaviours. Nevertheless, there is little evidence for their efficacy in adults with ASD. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| France | 1 | <1% |
| Canada | 1 | <1% |
| Taiwan | 1 | <1% |
| Unknown | 112 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 18 | 16% |
| Student > Doctoral Student | 13 | 11% |
| Student > Ph. D. Student | 12 | 10% |
| Student > Bachelor | 12 | 10% |
| Researcher | 10 | 9% |
| Other | 22 | 19% |
| Unknown | 29 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 32 | 28% |
| Psychology | 29 | 25% |
| Nursing and Health Professions | 7 | 6% |
| Social Sciences | 5 | 4% |
| Sports and Recreations | 4 | 3% |
| Other | 10 | 9% |
| Unknown | 29 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2019.
All research outputs
#7,244,861
of 25,654,806 outputs
Outputs from Psychopharmacology
#1,923
of 5,352 outputs
Outputs of similar age
#47,726
of 176,169 outputs
Outputs of similar age from Psychopharmacology
#16
of 38 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 5,352 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,169 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.